375 related articles for article (PubMed ID: 24247476)
1. The glucoregulatory benefits of glucagon-like peptide-1 (7-36) amide infusion during intensive insulin therapy in critically ill surgical patients: a pilot study.
Galiatsatos P; Gibson BR; Rabiee A; Carlson O; Egan JM; Shannon RP; Andersen DK; Elahi D
Crit Care Med; 2014 Mar; 42(3):638-45. PubMed ID: 24247476
[TBL] [Abstract][Full Text] [Related]
2. The effect of exogenous glucagon-like peptide-1 on the glycaemic response to small intestinal nutrient in the critically ill: a randomised double-blind placebo-controlled cross over study.
Deane AM; Chapman MJ; Fraser RJ; Burgstad CM; Besanko LK; Horowitz M
Crit Care; 2009; 13(3):R67. PubMed ID: 19439067
[TBL] [Abstract][Full Text] [Related]
3. Exogenous glucagon-like peptide-1 for hyperglycemia in critically ill patients.
Pinelli NR; Jones MC; Monday LM; Smith Z; Rhoney DH
Ann Pharmacother; 2012 Jan; 46(1):124-9. PubMed ID: 22202493
[TBL] [Abstract][Full Text] [Related]
4. Impact of a Paper-Based Dynamic Insulin Infusion Protocol on Glycemic Variability, Time in Target, and Hypoglycemic Risk: A Stepped Wedge Trial in Medical Intensive Care Unit Patients.
Clergeau A; Parienti JJ; Reznik Y; Clergeau D; Seguin A; Valette X; du Cheyron D; Joubert M
Diabetes Technol Ther; 2017 Feb; 19(2):115-123. PubMed ID: 28118045
[TBL] [Abstract][Full Text] [Related]
5. Lowering of glucose in critical care: a randomized pilot trial.
McMullin J; Brozek J; McDonald E; Clarke F; Jaeschke R; Heels-Ansdell D; Leppert R; Foss A; Cook D
J Crit Care; 2007 Jun; 22(2):112-8; discussion 118-9. PubMed ID: 17548021
[TBL] [Abstract][Full Text] [Related]
6. Effects of exogenous glucagon-like peptide-1 on gastric emptying and glucose absorption in the critically ill: relationship to glycemia.
Deane AM; Chapman MJ; Fraser RJ; Summers MJ; Zaknic AV; Storey JP; Jones KL; Rayner CK; Horowitz M
Crit Care Med; 2010 May; 38(5):1261-9. PubMed ID: 20228679
[TBL] [Abstract][Full Text] [Related]
7. Glucose control in the intensive care unit.
Fahy BG; Sheehy AM; Coursin DB
Crit Care Med; 2009 May; 37(5):1769-76. PubMed ID: 19325461
[TBL] [Abstract][Full Text] [Related]
8. Glucose-dependent insulinotropic polypeptide augments glucagon responses to hypoglycemia in type 1 diabetes.
Christensen M; Calanna S; Sparre-Ulrich AH; Kristensen PL; Rosenkilde MM; Faber J; Purrello F; van Hall G; Holst JJ; Vilsbøll T; Knop FK
Diabetes; 2015 Jan; 64(1):72-8. PubMed ID: 25053587
[TBL] [Abstract][Full Text] [Related]
9. Exogenous glucagon-like peptide-1 attenuates the glycaemic response to postpyloric nutrient infusion in critically ill patients with type-2 diabetes.
Deane AM; Summers MJ; Zaknic AV; Chapman MJ; Fraser RJ; Di Bartolomeo AE; Wishart JM; Horowitz M
Crit Care; 2011; 15(1):R35. PubMed ID: 21255422
[TBL] [Abstract][Full Text] [Related]
10. Standardization of intravenous insulin therapy improves the efficiency and safety of blood glucose control in critically ill adults.
Kanji S; Singh A; Tierney M; Meggison H; McIntyre L; Hebert PC
Intensive Care Med; 2004 May; 30(5):804-10. PubMed ID: 15127193
[TBL] [Abstract][Full Text] [Related]
11. The efficacy and safety of glucose control algorithms in intensive care: a pilot study of the Survival Using Glucose Algorithm Regulation (SUGAR) trial.
Henderson WR; Dhingra V; Chittock D; Foster D; Hebert P; Cook D; Heyland D; Dodek P; Griesdale D; Schulzer M; Ronco JJ;
Pol Arch Med Wewn; 2009; 119(7-8):439-46. PubMed ID: 19776683
[TBL] [Abstract][Full Text] [Related]
12. A randomized trial of hyperglycemic control in pediatric intensive care.
Macrae D; Grieve R; Allen E; Sadique Z; Morris K; Pappachan J; Parslow R; Tasker RC; Elbourne D;
N Engl J Med; 2014 Jan; 370(2):107-18. PubMed ID: 24401049
[TBL] [Abstract][Full Text] [Related]
13. Intravenous glucagon-like peptide 1 normalizes blood glucose after major surgery in patients with type 2 diabetes.
Meier JJ; Weyhe D; Michaely M; Senkal M; Zumtobel V; Nauck MA; Holst JJ; Schmidt WE; Gallwitz B
Crit Care Med; 2004 Mar; 32(3):848-51. PubMed ID: 15090972
[TBL] [Abstract][Full Text] [Related]
14. The incretin effect in critically ill patients: a case-control study.
Nielsen ST; Janum S; Krogh-Madsen R; Solomon TP; Møller K
Crit Care; 2015 Nov; 19():402. PubMed ID: 26567860
[TBL] [Abstract][Full Text] [Related]
15. Validation of an insulin infusion nomogram for intensive glucose control in critically ill patients.
Chant C; Wilson G; Friedrich JO
Pharmacotherapy; 2005 Mar; 25(3):352-9. PubMed ID: 15843282
[TBL] [Abstract][Full Text] [Related]
16. Effect of glucagon-like peptide-1 (GLP-1) on glycemic control and left ventricular function in patients undergoing coronary artery bypass grafting.
Sokos GG; Bolukoglu H; German J; Hentosz T; Magovern GJ; Maher TD; Dean DA; Bailey SH; Marrone G; Benckart DH; Elahi D; Shannon RP
Am J Cardiol; 2007 Sep; 100(5):824-9. PubMed ID: 17719327
[TBL] [Abstract][Full Text] [Related]
17. Intravenous GLP-1 (7-36) amide for prevention of hyperglycemia during cardiac surgery: a randomized, double-blind, placebo-controlled study.
Kohl BA; Hammond MS; Cucchiara AJ; Ochroch EA
J Cardiothorac Vasc Anesth; 2014 Jun; 28(3):618-25. PubMed ID: 24144627
[TBL] [Abstract][Full Text] [Related]
18. Design and rationale of Heart and Lung Failure - Pediatric INsulin Titration Trial (HALF-PINT): A randomized clinical trial of tight glycemic control in hyperglycemic critically ill children.
Agus MS; Hirshberg E; Srinivasan V; Faustino EV; Luckett PM; Curley MA; Alexander J; Asaro LA; Coughlin-Wells K; Duva D; French J; Hasbani N; Sisko MT; Soto-Rivera CL; Steil G; Wypij D; Nadkarni VM
Contemp Clin Trials; 2017 Feb; 53():178-187. PubMed ID: 28042054
[TBL] [Abstract][Full Text] [Related]
19. Effects of glucose-dependent insulinotropic polypeptide on gastric emptying, glycaemia and insulinaemia during critical illness: a prospective, double blind, randomised, crossover study.
Kar P; Cousins CE; Annink CE; Jones KL; Chapman MJ; Meier JJ; Nauck MA; Horowitz M; Deane AM
Crit Care; 2015 Jan; 19(1):20. PubMed ID: 25613747
[TBL] [Abstract][Full Text] [Related]
20. Clinical Impact of Accurate Point-of-Care Glucose Monitoring for Tight Glycemic Control in Severely Burned Children.
Tran NK; Godwin ZR; Steele AN; Wolf SE; Palmieri TL
Pediatr Crit Care Med; 2016 Sep; 17(9):e406-12. PubMed ID: 27472251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
